Pioneering immunotherapy drug Provenge is enjoying a revival, thanks to a large new clinical trial that will test it in men with early prostate cancer.
Selectively subduing a set of cells that migrate to the brain after a stroke occurs could meaningfully treat the stroke even days later.
In this In the Spotlight, Rebecca Saenz, a recent allergy and immunology fellow, describes her evolution as a physician/scientist and entrepreneur.
A method that broadens the pool of potential donors for stem cell transplants recently saved two young brothers from a severe genetic disease.
Third-year medical student Neil Rens explains why he chooses to advocate for stricter vaccination requirements in California.
Osteoarthritis has traditionally been thought to be an inevitable result of wear and tear. But it's now clear the immune system is playing a leading role.
Stanford researchers have developed a technique to encourage the immune system to target a section of the flu virus that is conserved year to year.
Stanford scientists and collaborators have harnessed CRISPR to replace the mutated gene underpinning the devastating immune disease, SCID-X1.
P. aeruginosa, a type of bacteria, is increasingly drug-resistant, and there's no vaccine against it. But it has a recently discovered Achilles heel.
Scientists have modified immune cells, imbuing them with the ability to not only detect, but reveal, the presence of a tumor.
Cracking the crystal structure of a protein complex centered around a major immune signaling protein, interferon-gamma, may speed its medical use.
A new blood test measures the DNA fragments of lung transplant donors in the blood of recipients, in hopes of preventing organ rejection and saving lives.
Stanford scientists have moved a big step closer toward using engineered immune cells to treat many forms of pediatric cancer.
New research has confirmed that an antigen in some variants of the flu virus and vaccine can, in rare cases, trigger an autoimmune response leading to narcolepsy.
Sharon Chinthrajah weighs in on a new peanut allergy immunotherapy, speaking to its potential and its role in the future of food allergies therapy.
With age comes wisdom: mostly true. But a new study helps explain why one part of us - our immune system - gets decidedly dumber with age.
